Clinical and Translational Radiation Oncology
ISSN: 2405-6308
Publisher: Elsevier
Publications (13)
ACO/ARO/AIO-22 – External beam radiotherapy combined with endorectal high-dose-rate brachytherapy in elderly and frail patients with rectal cancer: A prospective multicentre trial of the German Rectal Cancer Study Group (2025)
Dapper H, Fleischmann M, Tselis N, Diefenhardt M, Hofheinz RD, Weiß C, Grabenbauer GG, et al.
Journal article
Comparison of dose calculation approaches and clinical dose–response in image-guided head&neck brachytherapy of the oral cavity (2025)
Schaller S, Strnad V, Schweizer C, Lubgan D, Merten R, Fietkau R, Bert C, Karius A
Journal article
Letter to the Editor: Reply to Topkan et al (2025)
Schweizer C, Strnad V
Journal article
Postoperative brachytherapy alone for 217 patients with early-stage oral cavity squamous cell carcinoma (2025)
Schweizer C, Strnad V, Lotter M, Kreppner S, Merten R, Fietkau R, Karius A
Journal article
The current status of brachytherapy in Europe − A GEC-ESTRO Brachy-HERO survey (2025)
Johansen JG, Jürgenliemk-Schulz IM, Haddad H, Hannoun-Levi JM, Hellebust TP, Guix B, Loessl K, et al.
Journal article
Brachytherapy boost in anal canal cancer – A GEC ESTRO PDR task force meta-analysis (2023)
Annede P, Ferre M, Kirisits C, Pieters BR, Schmid M, Strnad V, Westerveld H, Chargari C
Journal article
Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis (2023)
Bodensohn R, Werner S, Reis J, Pazos Escudero M, Kaempfel AL, Hadi I, Forbrig R, et al.
Journal article
PD-1 and PD-L1 expression predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma (2022)
Göbel HH, Distel L, Aigner T, Büttner-Herold M, Grabenbauer GG
Journal article
Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged >= 60 years with Early-stage breast cancer (EPOPE): The rationale for a GEC-ESTRO randomized phase III-controlled trial (2021)
Hannoun-Levi JM, Chamorey E, Boulahssass R, Polgar C, Strnad V
Journal article
Definition and validation of a radiomics signature for loco-regional tumour control in patients with locally advanced head and neck squamous cell carcinoma (2021)
Meneghetti AR, Zwanenburg A, Leger S, Leger K, Troost EGC, Linge A, Lohaus F, et al.
Journal article